Bio-Thera Solutions, Ltd. (SHA:688177)

China · Delayed Price · Currency is CNY

22.62

+1.12 (5.21%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biopharmaceutical	743.17M	704.79M	455.13M	836.58M	182.86M
Biopharmaceutical Growth	5.44%	54.86%	-45.60%	357.49%	26023.37%
Total	743.17M	704.79M	455.13M	836.58M	182.86M
Total Growth	5.44%	54.86%	-45.60%	357.49%	26023.37%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	673.26M	-	-	-	184.99M
China Growth	-	-	-	-	26327.13%
Overseas	69.90M	-	-	-	-
Total	743.17M	-	-	-	184.99M
Total Growth	-	-	-	-	26327.13%

Source: S&P Global Market Intelligence.